Evoke Pharma (EVOK) Institutional Ownership $2.15 0.00 (0.00%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Evoke Pharma (NASDAQ:EVOK)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$461.93KNumber ofInstitutional Sellers(last 12 months)0 Get EVOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Evoke Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVOK Institutional Buying and Selling by Quarter Evoke Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Nantahala Capital Management LLC148,194$655K0.0%+163.5%9.946% 11/14/2024Corsair Capital Management L.P.11,667$56K0.0%N/A1.425% 11/9/2021BlackRock Inc.175,559$228K0.0%+9.2%0.541% 11/2/2021Raymond James Financial Services Advisors Inc.108,545$141K0.0%-8.9%0.335% 8/17/2021Worth Venture Partners LLC397,742$545K0.2%+18.2%1.229% 8/16/2021Sabby Management LLC47,431$65K0.0%N/A0.147% 8/13/2021Geode Capital Management LLC195,760$268K0.0%+22.4%0.605% 8/13/2021Vanguard Group Inc.1,120,178$1.53M0.0%-1.5%3.460% 8/12/2021AIGH Capital Management LLC1,701,185$2.33M0.4%+18.7%5.255% 5/20/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054% 5/19/2021Worth Venture Partners LLC336,516$616K0.3%N/A1.040% 5/18/2021Morgan Stanley723,897$1.33M0.0%+43.6%2.236% 5/18/2021Jane Street Group LLC18,044$33K0.0%N/A0.056% 5/13/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054% 5/12/2021UBS Group AG31,757$58K0.0%+1,709.5%0.098% 5/7/2021BlackRock Inc.150,891$276K0.0%+8.2%0.466% 2/9/2021Wells Fargo & Company MN25,117$65K0.0%+17,840.7%0.095% (Data available from 1/1/2016 forward) EVOK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVOK shares? During the previous two years, the following institutional investors and hedge funds held shares of Evoke Pharma shares: Nantahala Capital Management LLC ($655K), Corsair Capital Management L.P. ($56K).Learn more on EVOK's institutional investors. Which institutional investors have been buying Evoke Pharma stock? The following institutional investors have purchased Evoke Pharma stock in the last 24 months: Nantahala Capital Management LLC ($91.95K), and Corsair Capital Management L.P. ($11.67K). How much institutional buying is happening at Evoke Pharma? Institutional investors have bought a total of 103,612 shares in the last 24 months. This purchase volume represents approximately $461.93K in transactions. Related Companies SPRB Major Shareholders INAB Major Shareholders QNTM Major Shareholders SYBX Major Shareholders AFMD Major Shareholders MEIP Major Shareholders IMNN Major Shareholders CLDI Major Shareholders SLGL Major Shareholders ABVC Major Shareholders This page (NASDAQ:EVOK) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
